Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption

Use of bone turnover marker, pyridinolin

Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer

✍ Koga, Hirofumi; Naito, Seiji; Koto, Shuji; Sakamoto, Naotaka; Nakashima, Michita 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

BACKGROUND. We investigated whether a new marker of bone turnover, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), could be useful in the assessment of bone metastasis and in monitoring of the response to treatment in patients with prostate cancer with bone metastasi